Surprise Me!
FDA approves Celltrion’s biosimilar drug Remsima for sales in U.S.
2016-04-06
1
Dailymotion
Related Videos
FDA approves Celltrion’s biosimilar drug Remsima for sales in U.S.
FDA approves Celltrion’s biosimilar drug Remsima for sales in U.S.
U.S. FDA approves continuation of AstraZeneca's Phase III COVID-19 vaccine trials in the U.S.
U.S. FDA approves emergency authorization of convalescent plasma to treat COVID-19 patients
U.S. FDA approves first antigen test kit for COVID-19
U.S. FDA approves Moderna vaccine for emergency use
U.S. FDA approves emergency authorization of convalescent plasma to treat COVID-19 patients
U.S. FDA approves emergency authorization of convalescent plasma to treat COVID-19 patients
U.S. FDA approves Moderna's COVID-19 vaccine
U.S. FDA approves genetically modified salmon for human consumption
